{"description":"All-cause mortality is reported for all participants enrolled/randomized in the study. Serious adverse events and other adverse events are reported for all participants who received at least one dose of study drug.","eventGroups":[{"deathsNumAffected":28,"deathsNumAtRisk":57,"description":"One week of treatment with HC3 followed by 3 weeks of no treatment. The standard intensive consolidation chemotherapy course HC3 includes dexamethasone (10 mg/m\\^2/day IV on Days 1-6), vincrisitne (1.5 mg/m\\^2/day IV on Days 1 and 6), daunorubicin (30 mg/m\\^2 IV over 24 hours on Day 5), methotrexate (1 g/m\\^2 IV over 36 hours on Day 1), ifosfamide (800 mg/m\\^2 IV for 1 hour on Days 2-4), and pegylated \\[PEG\\]-asparaginase (1000 U/m\\^2 IV for 2 hours or IM on Day 6) or, if allergic, erwinia-asparaginase (20,000 units/m\\^2 IV or IM every 48 hours for a total of 6 doses).","id":"EG000","otherNumAffected":48,"otherNumAtRisk":52,"seriousNumAffected":24,"seriousNumAtRisk":52,"title":"HC3 Chemotherapy"},{"deathsNumAffected":11,"deathsNumAtRisk":54,"description":"One 4-week cycle of blinatumomab 15 μg/m\\^2/day as a continuous intravenous infusion (CIVI).","id":"EG001","otherNumAffected":54,"otherNumAtRisk":54,"seriousNumAffected":15,"seriousNumAtRisk":54,"title":"Blinatumomab"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":24,"numAtRisk":52},{"groupId":"EG001","numAffected":13,"numAtRisk":54}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":52},{"groupId":"EG001","numAffected":3,"numAtRisk":54}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Leukopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":52},{"groupId":"EG001","numAffected":5,"numAtRisk":54}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":52},{"groupId":"EG001","numAffected":4,"numAtRisk":54}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":52},{"groupId":"EG001","numAffected":2,"numAtRisk":54}],"term":"Aplasia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":52},{"groupId":"EG001","numAffected":7,"numAtRisk":54}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":52},{"groupId":"EG001","numAffected":4,"numAtRisk":54}],"term":"Abdominal pain upper"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":52},{"groupId":"EG001","numAffected":5,"numAtRisk":54}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":52},{"groupId":"EG001","numAffected":12,"numAtRisk":54}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":52},{"groupId":"EG001","numAffected":23,"numAtRisk":54}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Oral pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":27,"numAtRisk":52},{"groupId":"EG001","numAffected":11,"numAtRisk":54}],"term":"Stomatitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":52},{"groupId":"EG001","numAffected":17,"numAtRisk":54}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":52},{"groupId":"EG001","numAffected":3,"numAtRisk":54}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":52},{"groupId":"EG001","numAffected":9,"numAtRisk":54}],"term":"Mucosal inflammation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":52},{"groupId":"EG001","numAffected":43,"numAtRisk":54}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Hypertransaminasaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":52},{"groupId":"EG001","numAffected":6,"numAtRisk":54}],"term":"Hypogammaglobulinaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":4,"numAtRisk":54}],"term":"Immunodeficiency"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":3,"numAtRisk":54}],"term":"Nasopharyngitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":3,"numAtRisk":54}],"term":"Paronychia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Rhinitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":52},{"groupId":"EG001","numAffected":4,"numAtRisk":54}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Antithrombin III decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":52},{"groupId":"EG001","numAffected":2,"numAtRisk":54}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":52},{"groupId":"EG001","numAffected":2,"numAtRisk":54}],"term":"Fluid balance positive"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":52},{"groupId":"EG001","numAffected":5,"numAtRisk":54}],"term":"Neutrophil count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":52},{"groupId":"EG001","numAffected":7,"numAtRisk":54}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":4,"numAtRisk":54}],"term":"White blood cell count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":3,"numAtRisk":54}],"term":"Decreased appetite"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":52},{"groupId":"EG001","numAffected":6,"numAtRisk":54}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":52},{"groupId":"EG001","numAffected":3,"numAtRisk":54}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":52},{"groupId":"EG001","numAffected":2,"numAtRisk":54}],"term":"Pain in extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":52},{"groupId":"EG001","numAffected":20,"numAtRisk":54}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":5,"numAtRisk":54}],"term":"Tremor"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":4,"numAtRisk":54}],"term":"Agitation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":4,"numAtRisk":54}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":52},{"groupId":"EG001","numAffected":5,"numAtRisk":54}],"term":"Epistaxis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":52},{"groupId":"EG001","numAffected":2,"numAtRisk":54}],"term":"Oropharyngeal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":52},{"groupId":"EG001","numAffected":6,"numAtRisk":54}],"term":"Erythema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":4,"numAtRisk":54}],"term":"Petechiae"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":52},{"groupId":"EG001","numAffected":6,"numAtRisk":54}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":52},{"groupId":"EG001","numAffected":7,"numAtRisk":54}],"term":"Rash"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":3,"numAtRisk":54}],"term":"Rash maculo-papular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":3,"numAtRisk":54}],"term":"Urticaria"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Haematoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":52},{"groupId":"EG001","numAffected":7,"numAtRisk":54}],"term":"Hypertension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":52},{"groupId":"EG001","numAffected":6,"numAtRisk":54}],"term":"Hypotension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":52},{"groupId":"EG001","numAffected":4,"numAtRisk":54}],"term":"Anal inflammation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Hepatotoxicity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":4,"numAtRisk":54}],"term":"Hypervolaemia"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Leukopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Pancreatitis acute"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Stomatitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Hepatotoxicity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Hypertransaminasaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Bronchitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Clostridium difficile colitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Device related infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Escherichia bacteraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Herpes virus infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Klebsiella infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Perineal cellulitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Septic shock"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Accidental overdose"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Pneumothorax traumatic"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Blood immunoglobulin G decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Body temperature increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Lipase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Neurological examination abnormal"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Nervous system disorder"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":2,"numAtRisk":54}],"term":"Neurological symptom"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":2,"numAtRisk":54}],"term":"Seizure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Catheter placement"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Capillary leak syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Hypotension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Complication associated with device"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Engraftment syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":52},{"groupId":"EG001","numAffected":1,"numAtRisk":54}],"term":"Laryngotracheitis obstructive"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Staphylococcal infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Viral infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"Vulvitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 25.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":52},{"groupId":"EG001","numAffected":0,"numAtRisk":54}],"term":"B precursor type acute leukaemia"}],"timeFrame":"All-cause mortality is reported from randomization through the end of study; the median overall follow-up time was 55.2 months. Treatment-emergent adverse events are reported from the first dose of IP through the last dose of IP (up to Day 29) plus 30 days."}